trending Market Intelligence /marketintelligence/en/news-insights/trending/pwvj02yhl7ez78iufxrfba2 content esgSubNav
In This List

Onconova Therapeutics receives Nasdaq noncompliance notice

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Onconova Therapeutics receives Nasdaq noncompliance notice

Onconova Therapeutics Inc. said it was no longer in compliance with Nasdaq's minimum closing bid listing requirement of $1 per share.

The Newtown, Pa.-based company has until Nov. 5 to regain compliance by attaining the closing bid price of at least $1 per share for a minimum of 10 consecutive business days.

Onconova said it intends to monitor its closing bid price and was considering options to resolve the noncompliance issue.